Search

• Written by: L.M. Krug ×
• Journal or magazine: Lung Cancer ×
• Clear filters

1 result for “Reaction Department”

1. Medical study · Medical research · 2014

   Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma

   …in the two arms, aside from infusion reactions which occurred in 70% of patients treated with CBP501. While this randomized phase II trial met its primary endpoint of PFS at 4 months, other parameters such as…